Dose dense rituximab for high-risk children and adolescents with newly diagnosed acute immune thrombocytopenic purpura (ITP) (NCT04323748)

Authors
Category Systematic review
Conference67th American Society of Hematology Annual Meeting, ASH 2025
Year 2025
This article has no abstract
Epistemonikos ID: 83bc253f8c7505dc268db80f79d083339afd9890
First added on: Jun 10, 2026